DP
ARKG icon

DDD Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

DDD Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$446K Sell
16,872
-1,261
-7% -$36.9K 0.03% 102
2025
Q4 		$525K Sell
18,133
-17,706
-49% -$531K 0.03% 93
2025
Q3 		$995K Sell
35,839
-303
-0.8% -$7.66K 0.06% 77
2025
Q2 		$880K Buy
36,142
+401
+1% +$8.79K 0.09% 64
2025
Q1 		$742K Buy
35,741
+7,294
+26% +$183K 0.09% 62
2024
Q4 		$670K Sell
28,447
-126,370
-82% -$3.11M 0.08% 63
2024
Q3 		$3.96M Sell
154,817
-2,113
-1% -$53.8K 0.43% 40
2024
Q2 		$3.68M Sell
156,930
-2,342
-1% -$59.1K 0.43% 42
2024
Q1 		$4.58M Sell
159,272
-2,456
-2% -$73.9K 0.56% 39
2023
Q4 		$5.31M Sell
161,728
-2,744
-2% -$74.6K 0.71% 38
2023
Q3 		$4.12M Sell
164,472
-17,170
-9% -$561K 0.59% 39
2023
Q2 		$6.19M Buy
181,642
+605
+0.3% +$19K 0.86% 38
2023
Q1 		$5.44M Sell
181,037
-3,250
-2% -$101K 0.85% 37
2022
Q4 		$5.2M Buy
184,287
+1,332
+0.7% +$42.3K 0.83% 33
2022
Q3 		$6.01M Buy
182,955
+1,838
+1% +$67.5K 1.09% 33
2022
Q2 		$5.7M Buy
+181,117
New +$6.33M 0.99% 29

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

DDD Partners's ARKG Position: Q1 2026 in Review

DDD Partners reduced its ARK Genomic Revolution ETF (ARKG) stake by 7% in Q1 2026, selling an estimated $36.9K and leaving 16,872 shares worth $446K. The position accounts for 0.03% of the portfolio, ranked #102.

DDD Partners first reported a position in ARKG in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.19M in Q2 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • DDD Partners held 16,872 shares of ARK Genomic Revolution ETF worth $446K as of Q1 2026.
  • DDD Partners sold 1,261 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $36.9K.
  • ARK Genomic Revolution ETF made up 0.03% of DDD Partners's portfolio in Q1 2026, its #102 holding.
  • DDD Partners first reported a position in ARK Genomic Revolution ETF in Q2 2022 and has held it in 16 quarters since.
  • DDD Partners's ARK Genomic Revolution ETF position peaked at $6.19M in Q2 2023.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on DDD Partners's 13F filing for Q1 2026, filed 28 Apr 2026.